Why the study?
Endomyocardial biopsy is an invaluable and underused diagnostic tool for myocardial disease, with evolving techniques and indications across cardiac allograft rejection, inflammatory cardiomyopathy, and infiltrative cardiomyopathy.
Design
Clinical review
Authors
Loading...
Supports continued EMB role in allograft surveillance and select myocarditis; extends safety data while leaving non-invasive strategy trials open.
Endomyocardial biopsy remains a crucial diagnostic tool for cardiac allograft rejection and specific inflammatory cardiomyopathies, despite being replaced as a first-line test for infiltrative diseases.
Kiamanesh et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: